Cancer clinical trials have become increasingly complex - Timil Patel

Cancer clinical trials have become increasingly complex – Timil Patel

Cancer clinical trials have become increasingly complex, leading to inefficient data generation. Leaders from the FDA Oncology, the NCI, MSK Cancer Center, and ASCO discussed innovative ways to address these challenges at ASCO23.

Source: Timil Patel / Twitter

Cancer clinical trials have become increasingly complex - Timil Patel

Photo from Timil Patel’s Twitter

ASCO ASCO2023 clinical trials complex data FDA inefficient MSKCC NCI Timil Patel